Special items: Ovarian Cancer and Us blog best viewed in Firefox

Tuesday, June 15, 2010

Interleukin-6 as a therapeutic target in advanced ovarian cancer

Note: "Four of the eighteen patients completed 6 months of treatment and this included the partial responder who had continued decreases..."

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.